Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has provided an announcement.
The company held its third extraordinary general meeting for the fiscal year 2024, chaired by Ms. Wang Lei, at Da Ren Tang Mansion in Tianjin, China, with video conferencing for overseas shareholders in Singapore. During the meeting, voting for A-share shareholders was facilitated both on-site and online, ensuring broad participation from the company’s stakeholders.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company based in the People’s Republic of China, specializing in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, serving a diverse market base.
YTD Price Performance: -0.40%
Average Trading Volume: 511
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €3.51B
For detailed information about 2TZ stock, go to TipRanks’ Stock Analysis page.
